What This Top Dividend Portfolio Is Holding Now: AstraZeneca plc, HSBC Holdings plc And Vodafone Group plc

HSBC Holdings plc (LON:HSBA), AstraZeneca plc (LON:AZN) and Vodafone Group plc (LON:VOD) are heavyweight holdings of JP Morgan Claverhouse Investment Trust (LON:JCH).

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

JP Morgan Claverhouse IT (LSE: JCH) has a record of 41 consecutive years of dividend increases. At a current share price of 582p, the trust is on a trailing yield of 3.4%.

Picking great dividend shares has helped JP Morgan Claverhouse outperform the FTSE All-Share Index over the past three, five and 10 years.

Sectors in which the trust is currently overweight against the index include financials, healthcare and telecoms. The trust’s three biggest holdings in these three sectors are: HSBC (LSE: HSBA) (NYSE: HSBC.US), AstraZeneca (LSE: AZN) and Vodafone (LSE: VOD).

HSBC

Banking giant HSBC may have ditched its advertising slogan “The World’s Local Bank” a couple of years ago, but it has remained a convenient tag for financial hacks like me to emphasise the group’s global reach.

Geographical diversification helped HSBC get through the 2008/9 financial crisis. And while the company did reduce its dividend during those dark days, the payout has been growing at a good clip since, including a 9% rise for 2013.

City analysts are expecting a more modest 4% increase this year, followed by a 7% uplift for 2015. The recent market sell-off has seen HSBC’s shares hit a 52-week low of 589p, pushing the forward dividend yield up to a juicy 5.5% for investors today.

AstraZeneca

It’s been a good year for shareholders of AstraZeneca. The shares, which started the year at 3,600p, are currently trading at 4,427p on the back of the company’s strengthening drugs pipeline and management’s confident rejection of a 5,500p takeover offer from US pharma giant Pfizer.

The improving outlook hasn’t yet fed through to a rising dividend. Analysts are expecting the 2014 payout to be pegged at $2.80 for a fourth consecutive year, and for there to be little, if any, increase in 2015.

Nevertheless, the sterling translation of the dollar dividend equates to a yield of 4%, which is comfortably above the FTSE 100 average of 3.5%. And we could see the payout begin to rise pretty strongly further down the line.

Vodafone

Vodafone has been in a period of transition since selling its stake in US phones firm Verizon Wireless to Verizon Communications for £84bn earlier this year. The mobile giant’s earnings won’t — for at least a couple of years — cover the rising dividends the company hopes to pay.

Nevertheless, management reckons it can afford to lift the annual payouts, and signalled its confidence by raising the company’s recent interim dividend by 2%. If that carries through to the final dividend, as City analysts expect, we’d be looking at a forward yield of around 5.3% at a current share price of 213p.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended HSBC Holdings. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Lloyds shares just dipped below the £1 mark!

Lloyds shares are trading for pennies again! But is this a golden opportunity to pick up shares in the FTSE…

Read more »

ISA coins
Investing Articles

£10,000 put in a Cash ISA a decade ago is now worth…

What would have made someone the most money over the past 10 years -- a Cash ISA or Stocks and…

Read more »

A man with Down's syndrome serves a customer a pint of beer in a pub.
Investing Articles

Are Diageo shares about to pull a Rolls-Royce?

On many metrics, Diageo shares are looking somewhat similar to Rolls-Royce shares a few years back. Could history repeat itself?

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

1 big question to ask when thinking about what Nvidia stock could be worth

Christopher Ruane likes the look of the Nvidia business. But when it comes to its stock price, he's taking a…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

How has the Scottish Mortgage Investment Trust share price risen 57% in a year?

The Scottish Mortgage share price has soared over the last 12 months. After this kind of gain, investors might be…

Read more »

A young black man makes the symbol of a peace sign with two fingers
Investing Articles

I just bought this magnificent £2 UK growth stock for my Stocks and Shares ISA

Edward Sheldon just bought shares in this fast-growing British company for his Stocks and Shares ISA and he’s excited about…

Read more »

British pound data
Investing Articles

The stock market could plummet says the Bank of England

The Bank of England sees a number of risks on the horizon that could derail the stock market’s recent rally.…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Here’s how a £20,000 Stocks and Shares ISA could one day generate £14,947 of passive income a year

Can a five-figure Stocks and Shares ISA end up producing a five-figure annual passive income? This writer shows how it…

Read more »